Dr. Robert Dale Shultz

D.D.S. | Dentist



  
  5640 Clayton Cir, Roscoe
  Illinois, 61073-9503

  815-623-7366    815-623-7331 Maps & Directions
Dr. Robert Dale Shultz is a Roscoe, Illinois based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 5640 Clayton Cir, Roscoe. Patients can reach him at 815-623-7366.
Dr. Robert Dale Shultz is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Robert Dale Shultz speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Robert Dale Shultz
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:5640 Clayton Cir, Roscoe,
Illinois, 61073-9503
Phone:815-623-7366
Fax:815-623-7331
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 7810215803
Enrollment ID: I20150423002462
NPI Number: 1588753016
NPI Enumeration Date: 12 Oct, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 8180 Burr Oak Rd,
Roscoe, Illinois
Zip: 61073-9009
Phone Number: 815-623-6185
Patients can reach Dr. Robert Dale Shultz at 5640 Clayton Cir, Roscoe, Illinois or can call to book an appointment on 815-623-7366. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.

Comments/ Reviews: